Skip to main content
. 2016 Dec 1;46(6):270–273. doi: 10.4274/tjo.23921

Figure 3. Optical coherence tomography and fluorescein angiography images obtained from patient #3 at presentation and at 1 month after intravitreal bevacizumab injection.

Figure 3